[1]
“Linagliptin for Type 2 Diabetes Mellitus: A Systematic Review of Efficacy, Safety, Combination Therapy, and Use in High Risk Populations”, Faculty of Medicine, Tadulako University, P-ISSN: 2407-8441 and e-ISSN 2502-0749, vol. 12, no. 3, pp. 455–466, Jul. 2026, doi: 10.22487/vytnfy72.